Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
RAD001 in Metastatic Non-clear Cell Renal Cell Carcinoma
NCT00830895Phase 2Completed
- Sponsor
- Seoul National University Hospital
- Start
- Jan 2009
- Primary completion
- Oct 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of everolimus in non-clear cell renal cell carcinoma (nccRCC), sponsored by Seoul National University Hospital. Started Jan 2009; status: completed.
02
Drugs
everolimus
03
Conditions
non-clear cell renal cell carcinoma (nccRCC)
Beyond the preview
Go deeper on NCT00830895.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00830895.